CURRENT OPINION IN IMMUNOLOGY
主办单位:Elsevier Ltd
出版周期:
双月刊
语种:英文
国际刊号:0952-7915
期刊预警:
不在预警名单中
投稿经验(4)
医脉通用户1788951
2021-11-30 15:21:54
真是太慢了,去年12月份投的,这马上都快6月了,给编辑发有邮件,编辑说还在等审稿人意见,6个月还审不完一篇论文,有点不负责了,现在撤稿也不是,继续等也是无底洞,进退两难了
医脉通用户6863663
2021-09-16 08:20:05
真的牛逼,涨了2分直接5分多了这期刊。
医脉通用户7409046
2021-02-06 03:17:01
杂志出身背景好,定位高。
医脉通用户2783054
2020-11-16 14:48:05
投biomaterials悲剧之后,编辑让转投mt-b,还没有中科院分区好惨。
发布我的投稿经验
刊物简介
Current Opinion in Immunology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed.In Current Opinion in Immunology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.Current Opinion in Immunology will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students.Current Opinion in Immunology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is a companion to the new Gold Open Access journal Current Research in Immunology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.